首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

2044303

2034年微生物組靶向機能性食品市場預測：按產品類型、成分類型、應用、分銷管道、最終用戶和地區分類的全球分析

Microbiome-Targeted Functional Foods Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Application, Distribution Channel, End User and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，針對微生物組的機能性食品的全球市場預計將在 2026 年達到 78 億美元，並在預測期內以 9.7% 的複合年成長率成長，到 2034 年達到 164 億美元。

針對腸道菌叢的機能性食品指經過科學配方，能夠特異性調節腸道菌叢組成和代謝活性，從而獲得傳統營養無法實現的健康益處的食品。這些產品包括活性益生菌、由有益腸道細菌選擇性發酵的益生元（食物基材）、合益素（經高溫滅菌的細菌成分和發酵代謝產物），以及泡菜、Kefir、康普茶和Tempeh等發酵食品。其主要健康益處包括維持腸道屏障功能、免疫調節、減輕全身性發炎、透過腸-腦軸生成神經傳導物質前體，以及透過腸道菌叢介導的機制調節代謝激素。

腸道微生物組科學的主流化與消費者接受度

憑藉主流媒體對突破性腸道微生物組健康研究的報道、暢銷的腸道健康書籍以及串流媒體紀錄片，腸道微生物組健康研究的知名度空前高漲，培養了一批積極尋找有益於腸道微生物組的健康食品的消費者。醫療保健專業人員正將腸道微生物組健康諮詢納入預防醫學診療流程，從而催生了對特定益生菌和益生元食品類別的專家建議的需求。腸道微生物組在免疫系統發育、透過腸道腦軸影響心理健康以及預防代謝性疾病等方面的重要作用，使其在健康領域具有多重吸引力，並持續激發著不同健康意識群體消費者的濃厚興趣。

與菌株特異性和療效透明度相關的挑戰

消費者對益生菌功效中菌株特異性的困惑以及相關的科學複雜性，為產品選擇帶來了巨大挑戰，限制了一般健康消費者向針對特定微生物群產品的轉化率。如果益生菌產品的行銷未能揭露特定的菌株識別或相關的臨床證據，消費者幾乎不可能做出明智的選擇，並削弱了消費者對機能性食品功效宣稱的信心。多個市場的監管機構正加大力度，要求提供菌株特異性證據以支持健康益處宣稱，這給缺乏菌株層面臨床數據的傳統廣譜益生菌產品的配方帶來了挑戰。

精準客製化微生物組營養

將家用腸道微生物組檢測平台與個人化微生物組標靶機能性食品推薦服務結合，蘊藏著變革性的發展機會。將糞便微生物組定序分析與人工智慧驅動的膳食推薦演算法結合的公司，可以建立基於訂閱的精準營養方案，針對個別微生物組組成缺陷，制定特定的益生元基材、益生菌菌株和發酵食品的攝取計畫。這種整合診斷和營養的模式能夠顯著提升消費者參與度，實現高階定價，並產生長期的微生物組健康數據，從而有力地證明產品的有效性。

微生物組補充劑類別中的替代品

與機能性食品相比，益生菌補充劑因其更高的菌落形成單位計數、菌株特異性配方和更佳的保存期限優勢，正逐漸成為市場競爭的焦點，對以微生物組為靶點的食品構成威脅。尋求可衡量的微生物組健康益處的消費者可能更傾向於選擇可量化的高效補充劑，而非食品類產品，因為食品類產品在益生菌活性、確保和提供臨床適用劑量方面更具挑戰性。目前，益生菌補充劑市場憑藉其先進的臨床證據基礎和成熟的菌株特異性行銷策略，在表現上已超越大多數以微生物組為目標的食品。

新冠疫情的感染疾病：

新冠疫情大大提升了人們對免疫健康的關注度，加上臨床證據顯示腸道菌叢多樣性與免疫反應品質和新冠肺炎嚴重程度密切相關，消費者對有益於腸道菌叢的食品的需求空前高漲。疫情期間，發酵食品的銷售量在全球範圍內激增，消費者紛紛尋求透過飲食改善腸道健康的簡單方法。疫情結束後，人們對腸道健康作為一項基本健康要素的認知不斷提高，使得積極尋求有益於腸道菌群的機能性食品的消費者群體持續擴大，遠遠超出了疫情前的愛好者群體。

在預測期內，腸道健康零食市場預計將成為規模最大的市場。

在預測期內，腸道健康零食預計將佔據最大的市場佔有率。這主要歸功於零食形式的微生物組靶向機能性食品的便利性和易得性，消費者無需改變行為習慣即可將腸道健康益處融入日常飲食中。富含益生元纖維的點心棒、含益生菌的起司脆片和發酵蔬菜零食等產品已在龐大且成熟的功能性零食市場中佔據一席之地，並透過主流零售管道向廣大消費者傳遞微生物組的益處。

在預測期內，細菌菌株細分市場預計將呈現最高的複合年成長率。

在預測期內，細菌菌株細分市場預計將呈現最高的成長率。這主要歸功於新一代雙叉桿菌！針對特定健康狀況，具有臨床證據支持的新型高效細菌菌株的商業化生產規模不斷擴大，正在催生一個高階益生菌菌株原料市場，機能性食品生產商正將這些菌株應用於差異化的、針對特定微生物組的配方產品中。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於全球最發達的益生菌食品和膳食補充劑零售市場、消費者對腸道健康的高度關注，以及強大的機能性食品創新基礎設施，這些都為針對微生物產品類型開發提供了支持。美國在臨床微生物組研究的大量投資、先進的發酵食品新創企業生態系統以及醫療保健專業人員對膳食微生物組指導的整合等方面均處於領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這是因為該地區根深蒂固的傳統發酵食品文化，包括泡菜、味噌、納豆和Kefir，為消費者所熟知，並為針對腸道菌群的食品提供了成熟的消費環境。日本、韓國和中國政府的公共衛生營養計劃納入了腸道健康膳食建議，從而催生了機構需求；而印度和東南亞快速成長的機能性食品市場也為新消費者提供了巨大的接受度。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Nestle SA
Danone SA
PepsiCo Inc.
The Coca-Cola Company
General Mills Inc.
Kellogg Company
Yakult Honsha Co. Ltd.
Chr. Hansen Holding A/S
DuPont Nutrition & Biosciences
DSM-Firmenich
Arla Foods
Fonterra Co-operative Group
Chobani LLC
Lifeway Foods Inc.
Probi AB
BioGaia AB
Nestle Health Science

簡介目錄圖表

Product Code: SMRC36092

According to Stratistics MRC, the Global Microbiome-Targeted Functional Foods Market is accounted for $7.8 billion in 2026 and is expected to reach $16.4 billion by 2034 growing at a CAGR of 9.7% during the forecast period. Microbiome-targeted functional foods refer to food products scientifically formulated to specifically modulate the gut microbial ecosystem composition and metabolic activity to achieve documented health outcomes beyond conventional nutrition. These products deliver live probiotic microorganisms, prebiotic dietary substrates selectively fermented by beneficial gut bacteria, synbiotic combinations optimizing both microbial delivery and colonization, postbiotic heat-killed bacterial components and fermentation metabolites, and whole food fermented products including kimchi, kefir, kombucha, and tempeh. Health targets addressed include gut barrier integrity, immune modulation, systemic inflammation reduction, neurotransmitter precursor production through the gut-brain axis, and metabolic hormone regulation through microbiome-mediated mechanisms.

Market Dynamics:

Driver:

Gut microbiome science mainstreaming and consumer adoption

Unprecedented public exposure to gut microbiome health research through mainstream media coverage of landmark microbiome studies, bestselling gut health books, and streaming documentary content has created a broadly informed consumer audience actively seeking microbiome-targeted food products. Healthcare provider integration of microbiome health counseling into preventive medicine consultations is generating professional recommendation demand for specific probiotic and prebiotic food categories. The gut microbiome's documented roles in immune system development, mental health through the gut-brain axis, and metabolic disease prevention are providing multi-pathway benefit communication that sustains strong consumer investment across diverse health motivation demographics.

Restraint:

Strain specificity and efficacy transparency challenges

Consumer confusion and scientific complexity around the strain-specific nature of probiotic benefits creates significant product selection challenges that limit category conversion rates from general wellness consumers to specific microbiome-targeted product commitment. The marketing of probiotic products without disclosure of specific strain identifiers and associated clinical evidence makes informed consumer selection effectively impossible, reducing consumer confidence in functional food efficacy claims. Regulatory authorities in multiple markets are increasing pressure for strain-specific evidence substantiation for health claims that challenges legacy broad-spectrum probiotic product formulations lacking strain-level clinical documentation.

Opportunity:

Precision microbiome nutrition personalization

At-home gut microbiome testing platform integration with personalized microbiome-targeted functional food recommendation services represents a transformative market development opportunity. Companies combining stool microbiome sequencing analysis with AI-powered dietary recommendation algorithms can create subscription-based precision nutrition programs that prescribe specific prebiotic substrates, probiotic strains, and fermented food regimens tailored to individual microbiome composition gaps. This diagnostic-nutrition integration model creates superior consumer engagement, enables premium pricing, and generates longitudinal microbiome health data supporting compelling product efficacy demonstration.

Threat:

Microbiome supplement category substitution

Competitive substitution from concentrated probiotic supplement formats offering higher colony-forming unit counts, strain-specific formulations, and storage-stable convenience compared to functional food delivery vehicles threatens microbiome-targeted food product market positioning. Consumers seeking measurable microbiome health outcomes may prefer quantifiable high-potency supplement interventions over food-format products whose probiotic viability and clinically relevant dosage delivery are more difficult to guarantee and communicate. The probiotic supplement market's advanced clinical evidence base and strain-specific marketing sophistication currently exceeds that of most microbiome-targeted food products.

Covid-19 Impact:

The pandemic's dramatic elevation of immune health consciousness combined with clinical evidence linking gut microbiome diversity to immune response quality and COVID-19 outcome severity created unprecedented consumer demand for microbiome-supporting foods. Fermented food category sales surged globally during the pandemic period as consumers sought accessible gut health improvement through dietary means. Post-pandemic, structural elevation of gut health as a foundational wellness priority has permanently expanded the consumer base actively seeking microbiome-targeted functional food products beyond pre-pandemic enthusiast segments.

The gut health snacks segment is expected to be the largest during the forecast period

The gut health snacks segment is expected to account for the largest market share during the forecast period, due to the convenience and accessibility of snack format microbiome-targeted functional foods that integrate gut health benefits into everyday consumption occasions without requiring behavioral routine modification. Prebiotic fiber-enriched snack bars, probiotic-containing cheese crisps, and fermented vegetable snack formats provide competitive positioning within the large and established functional snack category, enabling microbiome benefit delivery through mainstream retail channels with broad consumer demographic appeal.

The bacterial strains segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the bacterial strains segment is predicted to witness the highest growth rate, driven by rapid advancement in next-generation probiotic strain discovery, including Akkermansia muciniphila, Faecalibacterium prausnitzii, and Ligilactobacillus reuteri strains with documented superior health benefit profiles compared to legacy Lactobacillus acidophilus and Bifido standards. Commercial production scale-up of novel high-efficacy bacterial strains with clinical evidence for specific health conditions is creating premium probiotic strain ingredient markets that functional food manufacturers are integrating into differentiated microbiome-targeted product formulations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the world's most developed probiotic food and supplement retail market, high consumer gut health awareness, and strong functional food innovation infrastructure supporting microbiome-targeted product category development. The United States leads with significant investment in clinical microbiome research, advanced fermented food startup ecosystems, and growing healthcare provider integration of dietary microbiome guidance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to deep-rooted traditional fermented food cultures including kimchi, miso, natto, and kefir providing consumer familiarity and established consumption occasions for microbiome-targeted foods. Government public health nutrition programs in Japan, South Korea, and China incorporating gut health dietary recommendations are creating institutional demand, while rapidly expanding functional food markets in India and Southeast Asia offer substantial new consumer adoption opportunities.

Key players in the market

Some of the key players in Microbiome-Targeted Functional Foods Market include Nestle S.A., Danone S.A., PepsiCo Inc., The Coca-Cola Company, General Mills Inc., Kellogg Company, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, DSM-Firmenich, Arla Foods, Fonterra Co-operative Group, Chobani LLC, Lifeway Foods Inc., Probi AB, BioGaia AB, and Nestle Health Science.

Key Developments:

In March 2026, Chr. Hansen Holding A/S launched a next-generation probiotic ingredient platform incorporating Akkermansia muciniphila for functional food manufacturers targeting gut barrier health and metabolic wellness positioning.

In February 2026, BioGaia AB introduced a new functional food grade Ligilactobacillus reuteri strain with clinically documented superior gut colonization and immune modulation activity compared to standard Lactobacillus strains.

In January 2026, Yakult Honsha Co. Ltd. expanded its microbiome-targeted functional beverage portfolio with a synbiotic formulation combining proprietary Lactobacillus casei Shirota with novel prebiotic oligosaccharide substrate.

Product Types Covered:

Probiotic Foods
Prebiotic Foods
Synbiotic Products
Fermented Foods
Gut Health Snacks

Ingredient Types Covered:

Bacterial Strains
Fiber-Based Prebiotics
Plant Extracts
Enzymes
Postbiotics

Applications Covered:

Digestive Health
Immune Support
Metabolic Health
Mental Wellness
Weight Management

Distribution Channels Covered:

Supermarkets/Hypermarkets
Online Retail
Pharmacies
Specialty Stores
Health Clinics

End Users Covered:

Adults
Children
Geriatric Population
Fitness Consumers
Patients

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Microbiome-Targeted Functional Foods Market, By Product Type

5.1 Probiotic Foods
5.2 Prebiotic Foods
5.3 Synbiotic Products
5.4 Fermented Foods
5.5 Gut Health Snacks

6 Global Microbiome-Targeted Functional Foods Market, By Ingredient Type

6.1 Bacterial Strains
6.2 Fiber-Based Prebiotics
6.3 Plant Extracts
6.4 Enzymes
6.5 Postbiotics

7 Global Microbiome-Targeted Functional Foods Market, By Application

7.1 Digestive Health
7.2 Immune Support
7.3 Metabolic Health
7.4 Mental Wellness
7.5 Weight Management

8 Global Microbiome-Targeted Functional Foods Market, By Distribution Channel

8.1 Supermarkets/Hypermarkets
8.2 Online Retail
8.3 Pharmacies
8.4 Specialty Stores
8.5 Health Clinics

9 Global Microbiome-Targeted Functional Foods Market, By End User

9.1 Adults
9.2 Children
9.3 Geriatric Population
9.4 Fitness Consumers
9.5 Patients

10 Global Microbiome-Targeted Functional Foods Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Nestle S.A.
13.2 Danone S.A.
13.3 PepsiCo Inc.
13.4 The Coca-Cola Company
13.5 General Mills Inc.
13.6 Kellogg Company
13.7 Yakult Honsha Co. Ltd.
13.8 Chr. Hansen Holding A/S
13.9 DuPont Nutrition & Biosciences
13.10 DSM-Firmenich
13.11 Arla Foods
13.12 Fonterra Co-operative Group
13.13 Chobani LLC
13.14 Lifeway Foods Inc.
13.15 Probi AB
13.16 BioGaia AB
13.17 Nestle Health Science

簡介目錄圖表

List of Tables

Table 1 Global Microbiome-Targeted Functional Foods Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Microbiome-Targeted Functional Foods Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Microbiome-Targeted Functional Foods Market Outlook, By Probiotic Foods (2023-2034) ($MN)
Table 4 Global Microbiome-Targeted Functional Foods Market Outlook, By Prebiotic Foods (2023-2034) ($MN)
Table 5 Global Microbiome-Targeted Functional Foods Market Outlook, By Synbiotic Products (2023-2034) ($MN)
Table 6 Global Microbiome-Targeted Functional Foods Market Outlook, By Fermented Foods (2023-2034) ($MN)
Table 7 Global Microbiome-Targeted Functional Foods Market Outlook, By Gut Health Snacks (2023-2034) ($MN)
Table 8 Global Microbiome-Targeted Functional Foods Market Outlook, By Ingredient Type (2023-2034) ($MN)
Table 9 Global Microbiome-Targeted Functional Foods Market Outlook, By Bacterial Strains (2023-2034) ($MN)
Table 10 Global Microbiome-Targeted Functional Foods Market Outlook, By Fiber-Based Prebiotics (2023-2034) ($MN)
Table 11 Global Microbiome-Targeted Functional Foods Market Outlook, By Plant Extracts (2023-2034) ($MN)
Table 12 Global Microbiome-Targeted Functional Foods Market Outlook, By Enzymes (2023-2034) ($MN)
Table 13 Global Microbiome-Targeted Functional Foods Market Outlook, By Postbiotics (2023-2034) ($MN)
Table 14 Global Microbiome-Targeted Functional Foods Market Outlook, By Application (2023-2034) ($MN)
Table 15 Global Microbiome-Targeted Functional Foods Market Outlook, By Digestive Health (2023-2034) ($MN)
Table 16 Global Microbiome-Targeted Functional Foods Market Outlook, By Immune Support (2023-2034) ($MN)
Table 17 Global Microbiome-Targeted Functional Foods Market Outlook, By Metabolic Health (2023-2034) ($MN)
Table 18 Global Microbiome-Targeted Functional Foods Market Outlook, By Mental Wellness (2023-2034) ($MN)
Table 19 Global Microbiome-Targeted Functional Foods Market Outlook, By Weight Management (2023-2034) ($MN)
Table 20 Global Microbiome-Targeted Functional Foods Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 21 Global Microbiome-Targeted Functional Foods Market Outlook, By Supermarkets/Hypermarkets (2023-2034) ($MN)
Table 22 Global Microbiome-Targeted Functional Foods Market Outlook, By Online Retail (2023-2034) ($MN)
Table 23 Global Microbiome-Targeted Functional Foods Market Outlook, By Pharmacies (2023-2034) ($MN)
Table 24 Global Microbiome-Targeted Functional Foods Market Outlook, By Specialty Stores (2023-2034) ($MN)
Table 25 Global Microbiome-Targeted Functional Foods Market Outlook, By Health Clinics (2023-2034) ($MN)
Table 26 Global Microbiome-Targeted Functional Foods Market Outlook, By End User (2023-2034) ($MN)
Table 27 Global Microbiome-Targeted Functional Foods Market Outlook, By Adults (2023-2034) ($MN)
Table 28 Global Microbiome-Targeted Functional Foods Market Outlook, By Children (2023-2034) ($MN)
Table 29 Global Microbiome-Targeted Functional Foods Market Outlook, By Geriatric Population (2023-2034) ($MN)
Table 30 Global Microbiome-Targeted Functional Foods Market Outlook, By Fitness Consumers (2023-2034) ($MN)
Table 31 Global Microbiome-Targeted Functional Foods Market Outlook, By Patients (2023-2034) ($MN)